Key result
Patients with active rheumatoid arthritis presenting with acute coronary syndrome had higher 30-day all-cause mortality compared with matched controls (15.7% vs. 10.7%).
Why the study?
Does active rheumatoid arthritis increase short-term mortality in patients presenting with acute coronary syndrome?
Population
Patients with active rheumatoid arthritis presenting with an incident acute coronary syndrome.
Design
Editorial
Follow-up
30 days
Authors
Loading...
Rheumatoid arthritis and atherosclerosis share inflammatory pathophysiological mechanisms, contributing to more severe acute coronary syndrome presentations and higher short-term mortality in patients with rheumatoid arthritis.
Does active rheumatoid arthritis increase short-term mortality in patients presenting with acute coronary syndrome?
Absolute Event Rate: 15.7% vs 10.7%
Rheumatoid arthritis and atherosclerosis share inflammatory pathophysiological mechanisms, contributing to more severe acute coronary syndrome presentations and higher short-term mortality in patients with rheumatoid arthritis.
Klingenberg et al. (2015) conducted an editorial in Rheumatoid arthritis and acute coronary syndrome. Active rheumatoid arthritis vs. Matched controls was evaluated on 30-day all-cause mortality after an ACS. Patients with active rheumatoid arthritis presenting with acute coronary syndrome had higher 30-day all-cause mortality compared with matched controls (15.7% vs. 10.7%).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: